Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000258145 | SCV000328329 | pathogenic | CHARGE association | 2016-09-05 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000258145 | SCV000594104 | pathogenic | CHARGE association | 2016-08-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000760387 | SCV000890252 | pathogenic | not provided | 2021-11-17 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 25525159, 30244528, 16400610, 29300383) |
Fulgent Genetics, |
RCV000763599 | SCV000894444 | pathogenic | CHARGE association; Hypogonadotropic hypogonadism 5 with or without anosmia | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000258145 | SCV001585635 | pathogenic | CHARGE association | 2023-07-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg1069*) in the CHD7 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CHD7 are known to be pathogenic (PMID: 22461308, 25077900). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with CHARGE syndrome (PMID: 16400610, 29300383). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 267423). For these reasons, this variant has been classified as Pathogenic. |
3billion | RCV000258145 | SCV004013513 | pathogenic | CHARGE association | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. The variant is predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000267423 / PMID: 16400610). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. | |
Sbielas Lab- |
RCV000258145 | SCV000680054 | pathogenic | CHARGE association | 2017-10-27 | no assertion criteria provided | research | |
University of Washington Center for Mendelian Genomics, |
RCV000258145 | SCV001197960 | likely pathogenic | CHARGE association | no assertion criteria provided | research |